Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.81), $1.59 better than the analyst estimate of ($2.40). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $36.89 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.